0
Positivia HIV-1 p24 Ag Rapid Test Control Kit
Catalog No :
CAS Number :
Brand :
In Stock
Specifications:
| Application | Quality Control | ||
| Storage Temperature | 2-8°C | ||
| Product Type | Test Controls | Forms | Kit with Various components |
| Product Brand | CTK Biotech | ||
| Product Grade | Medical grade | ||
The Positivia HIV-1 p24 Ag Rapid Test Control Kit is an external quality control set designed for use with the OnSite HIV Ag/Ab 4th Generation Rapid Test. It provides positive and negative controls for the HIV-1 p24 antigen, ensuring that each test run performs as expected and maintains diagnostic accuracy.
By including this control kit in routine workflows, laboratories and field testing teams can validate test integrity, reagent performance, and procedural accuracy, supporting compliance with quality assurance standards.
Kit Contents
- HIV-1 p24 Ag Positive Control
- HIV-1 p24 Ag Negative Control
- Package insert with instructions for use
Compatible Rapid Tests
| Catalog Number | Product | Quantity | Specimen Types |
|---|---|---|---|
| R0018C | HIV Ag/Ab 4th Gen. Rapid Test | 30/kit | Serum (S), Plasma (P), Whole Blood (WB) |
Key Features
- Provides external assay controls for HIV-1 p24 antigen testing.
- Ensures accurate performance monitoring of the OnSite HIV Ag/Ab 4th Gen. Rapid Test.
- Includes both positive and negative HIV-1 p24 controls.
- Long 24-month shelf life.
- Supports quality assurance and compliance in rapid HIV testing.
Applications
- Clinical Laboratories: Routine HIV rapid test quality assurance.
- Public Health Programs: HIV screening campaigns and surveillance.
- Field Testing: Reliable QC for point-of-care HIV diagnostics.
- Training & Research: Teaching and evaluating HIV diagnostic workflows.
The Positivia HIV-1 p24 Ag Rapid Test Control Kit (C0018) is a reliable external control tool for ensuring test accuracy, reproducibility, and compliance in HIV rapid diagnostic workflows. Compatible with the OnSite HIV Ag/Ab 4th Gen. Rapid Test (R0018C), it provides both positive and negative controls, giving confidence in results for clinical, public health, and field-based HIV testing programs.